Pharmerica Whistleblower Can’t Reinstate False Claims Act Suit

Pharmerica Corp. and others stopped a whistleblower’s bid to revive a False Claims Act suit alleging that they engaged in schemes to improperly bill Medicare and Medicaid for prescription drugs, according to a Friday decision by the Second Circuit.

Whistleblower and pharmacist Kaveh Askari appealed after a New York federal district court dismissed his suit, and then denied his motion to file an amended complaint.

Askari alleged that Pharmerica worked with defendant Onco360 to dispense drug prescriptions in various states even though Onco360 had lost its out-of-state pharmacy licenses. The violation of out-of-state pharmacy licensing laws caused false claims to ...